ESTUDIO DE EXTENSIÓN, MULTICÉNTRICO, ALEATORIZADO, CON DOS PERÍODOS, DOBLE CIEGO CONTROLADO CON PLACEBO Y ABIERTO, PARA DETERMINAR LA SEGURIDAD Y TOLERABILIDAD A LARGO PLAZO DE JNJ-54861911 EN SUJETOS EN EL ESPECTRO DE ENFERMEDAD DE ALZHEIMER TEMPRANA.

Article. 10.1016/j.clinbiochem.2019.07.008. 2019

Assessment of Lipid Peroxidation in Alzheimer's Disease Differential Diagnosis and Prognosis.

Ferre-Gonzalez, Laura; (...); Chafer-Pericas, Consuelo

Article. 10.3390/antiox11030551. 2022

Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer's Disease and Frontotemporal Dementia.

Álvarez-Sánchez L; (...); Cháfer-Pericás C

Article. 10.3390/ijms24021226. 2023

Assessment of Screening Approach in Early and Differential Alzheimer's Disease Diagnosis.

Ferré-González L; (...); Cháfer-Pericás C

Article. 10.3390/antiox10111662. 2021

Assessment of the quality of sample labelling for clinical research.

Pérez-Huertas P; (...); Poveda-Andrés JL

Article. 10.7399/fh.2016.40.2.9753. 2016

Associations between antidiabetic medications and cerebrospinal fluid biomarkers of Alzheimer's disease.

Garcia-Lluch, Gemma; (...); Chafer-Pericas, Consuelo

Article. 10.1177/13872877241304995. 2024

Attitudes toward seeking professional help among patients with early Alzheimer's disease

Villarejo-Galende, A.; (...); Maurino, J.

Meeting Abstract. 2023

ATYPICAL HEALING IN A CASE WITH RETINAL PIGMENT EPITHELIUM APERTURES.

Molina-Pallete R; (...); Dolz-Marco R

Article. 10.1097/ICB.0000000000000789. 2018

Awareness of Diagnosis in Persons with Early-Stage Alzheimer's Disease: An Observational Study in Spain.

Villarejo-Galende, Alberto; (...); Maurino, Jorge

Article. 10.1007/s40120-022-00367-3. 2022

Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.

Iglesias Gómez R; (...); Poveda Andrés JL

Article. 10.1136/ejhpharm-2021-002741. 2021

Bayesian pharmacokinetic individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018

Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A

Article. 10.1016/j.thromres.2018.12.027. 2019

Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.

Fernandez Rivera C; (...); Hernandez D

Article. 10.1111/ctr.14550. 2022

BK Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation in the Pediatric Population

Perez-Huertas, P; (...); Poveda-Andres, JL

Article. 10.1177/1043454216631952. 2017

Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis

Article. 10.1111/ane.12863. 2018

Breakthrough invasive fungal disease in high-risk hematologic malignancies in children: a single-center experience

Garcia-Robles, AA; (...); Fernandez-Navarro, JM

Meeting Abstract. 2017

Cardiovascular Risk Scales Association with Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cardiovascular Low Cardiovascular Risk Regions.

García-Lluch G; (...); Cháfer-Pericás C

Article. 10.14283/jpad.2024.16. 2024

Clinical and genetic characteristics of 21 Spanish patients with biallelic pathogenic SPG7 mutations.

Baviera-Muñoz R; (...); Espinós C

Article. 10.1016/j.jns.2021.118062. 2021

Clinical and Magnetic Resonance Imaging features of a series of 11 Spanish patients who carry mutations in the BICD2 gene

Carrera, MF; (...); Sevilla, T

Meeting Abstract. 2018

Clinical and neuroimaging characterization of two C9orf72-positive siblings with amyotrophic lateral sclerosis and schizophrenia

Vázquez-Costa JF; (...); Sevilla T

Article. 10.3109/21678421.2015.1112407. 2016

Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients

Article. 10.1016/j.thromres.2021.07.009. 2021

Clinical evaluation of rituximab treatment for neuromyelitis optica

Fernández-Megía MJ; (...); Poveda-Andrés JL

Article. 10.1016/j.nrl.2014.09.001. 2015

Clinical features, mutation spectrum and factors related to reaching molecular diagnosis in a cohort of patients with distal myopathies.

Muelas, Nuria; (...); Vilchez, Juan J

Article. 10.1007/s00415-024-12821-3. 2025

Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model

Nogueras, A; (...); Calleja, MA

Letter. 10.1136/ejhpharm-2019-001905. 2019

Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder

Article. 10.1016/j.jns.2017.04.053. 2017

Clinical spectrum of BICD2 mutations.

Frasquet M; (...); Sevilla T

Article. 10.1111/ene.14173. 2020

Clinical trials in pediatric ALS: a TRICALS feasibility study.

Kliest T; (...); Van Den Berg LH

Article. 10.1080/21678421.2021.2024856. 2022

Clinical usefulness of cerebrospinal fluid biomarkers in Alzheimer Disease.

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Article. 10.1111/eci.13910. 2022

Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer's Disease Differential Diagnosis

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Article. 10.3390/antiox9080649. 2020

COGNITIVE FUNCTION FOLLOWING AN INTRACEREBRAL HEMORRHAGE ASSOCIATED WITH CEREBRAL AMYLOID ANGIOPATHY.

Gimenez, C; (...); Lago, A

Meeting Abstract. 2020

Collaborative model of home delivery program in haemophilia through an association of patients

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018

Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo

Meeting Abstract. 2020

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023

COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA

Gironella, M.; (...); Oyaguez, I

Meeting Abstract. 2019

COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN

Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.

Meeting Abstract. 2024

Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1080/13696998.2017.1311903. 2017

Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.

Poveda JL; (...); Torres C

Article. 10.1080/14737167.2019.1635014. 2020

COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN

Trillo, JL; (...); Torres, C

Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018

COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN

Bonanad, S; (...); Gonzalez-Dominguez, A

Meeting Abstract. 2020

Costs of the management of hemophilia A with inhibitors in Spain

Bonanad, S; (...); Gonzalez-Dominguez, A

Article. 10.33393/grhta.2021.2234. 2021

Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis

Letter. 10.1111/hae.13733. 2019

Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Eduardo Megias, Juan; (...); Iorio, Alfonso

Meeting Abstract. 10.1182/blood-2019-127946. 2019

Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.

Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL

Editorial Material. 10.1016/j.farma.2024.08.001. 2024

Characterising the phenotype and mode of inheritance of patients with inherited peripheral neuropathies carrying MME mutations

Lupo, V; (...); SEVILLA, T

Article. 10.1136/jmedgenet-2018-105650. 2018

Characterizing SOD1 mutations in Spain. The impact of genotype, age, and sex in the natural history of the disease.

Vazquez-Costa, Juan F.; (...); Garcia-Redondo, Alberto

Article. 10.1111/ene.15661. 2022

Charcot-Marie-Tooth disease due to MORC2 mutations in Spain

Sivera R; (...); Sevilla T

Article. 10.1111/ene.15001. 2021

Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.1080/17512433.2019.1573668. 2019

Decreased spasticity in primary lateral sclerosis after botulinum toxin injection: A case report

Cea, AA; (...); Salazar, MG

Letter. 10.1016/j.nrl.2016.01.005. 2018

Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project

Blade, J; (...); Lizan, L

Article. 10.1136/bmjopen-2017-018850. 2018

Defining Alzheimer's Disease through Proteomic CSF Profiling.

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Article. 10.1021/acs.jproteome.4c00590. 2024

Delphi consensus on recommendations for the treatment of spinal muscular atrophy in Spain (RET-AME consensus)

Pitarch Castellano, I; (...); Vazquez-Costa, J. F.

Article. 10.1016/j.nrl.2021.07.008. 2022

Delphi consensus on recommendations for the treatment of spinal muscular atrophy in Spain (RET-AME consensus).

Pitarch Castellano I; (...); Vázquez-Costa JF

Practice Guideline. 10.1016/j.nrleng.2021.07.002. 2022

Depression and Suicide Risk in Mild Cognitive Impairment: The Role of Alzheimer's Disease Biomarkers

Ferrer-Cairols, Ines; (...); Salvador, Alicia

Article. 10.7334/psicothema2022.103. 2022

Depressive symptoms in neurodegenerative diseases.

Baquero, M, Martin, N

Article. 10.12998/wjcc.v3.i8.682. 2015

DESCRIPTION OF A CLUSTER OF PATIENTS WITH THE HSPB1 P.R140G MUTATION

Frasquet, M.; (...); Sevilla, T.

Meeting Abstract. 2016

Description of a series of Spanish patients carrying the HSPB1 p.r140g mutation

Carrera, MF; (...); Mantecon, MTS

Meeting Abstract. 2017

Descriptive analysis of the spinal muscular atrophy population treated with Nusinersen included in the CuidAME project

Sotoca Fernandez, J.; (...); Fernandez-Garcia, M.

Meeting Abstract. 10.1016/j.nmd.2024.07.462. 2024

Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.

Salinas P; (...); Escaned J

Article. 10.1016/j.carrev.2021.11.015. 2021

Design and Validation of a Clinical Outcome Measure for Adolescents and Adult Patients with Spinal Muscular Atrophy: SMA Life Study Protocol

Rebollo, Pablo; (...); Vazquez-Costa, Juan F.

Article. 10.1007/s40120-023-00571-9. 2024

Design of a Non-Interventional Study to Validate a Set of Patient- and Caregiver-Oriented Measurements to Assess Health Outcomes in Spinal Muscular Atrophy (SMA-TOOL Study).

Madruga-Garrido M; (...); Maurino J

Article. 10.1007/s40120-020-00229-w. 2021

Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis

Alvarez-Roman, MT; (...); Badia, X

Article. 10.1177/2284240319880534. 2019

DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)

Alvarez, E.; (...); Badia, F. J.

Meeting Abstract. 2019

Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024

Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024

DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN

Poveda, J. L.; (...); Vitoria, I

Meeting Abstract. 2019

Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain

Badia, X; (...); Poved, JL

Article. 10.1080/21678707.2019.1652163. 2019

Diagnostic delay and pathway analysis in paediatric Charcot-Marie-Tooth disease

Argente-Escrig, H; (...); Mantecon, MTS

Meeting Abstract. 2019

Diagnostic Efficacy of Genetic Studies in a Series of Hereditary Cerebellar Ataxias in Eastern Spain.

Baviera-Munoz, Raquel; (...); Aller, Elena

Article. 10.1212/NXG.0000000000200038. 2022

Discordant Amyloid Status Diagnosis in Alzheimer's Disease.

García-Vallés L; (...); Cháfer-Pericás C

Article. 10.3390/biomedicines10112880. 2022

Distal hereditary motor neuropathies: mutation spectrum and genotype-phenotype correlation.

Frasquet, Marina; (...); Lupo, Vincenzo

Article. 10.1111/ene.14700. 2021

Do we really need to calculate a minimal important difference for ALSFRS-R?: A letter in response to 'Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R' published in Vol. 24(3-4), pp. 311-316

Vázquez-Costa JF

Article. 10.1080/21678421.2023.2248199. 2024

Early Alzheimer's Disease Screening Approach Using Plasma Biomarkers

Alvarez-Sanchez, Lourdes; (...); Chafer-Pericas, Consuelo

Article. 10.3390/ijms241814151. 2023

Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases

Review. 10.1007/s10072-017-2833-9. 2017

Early neurotransmission impairment in non-invasive Alzheimer Disease detection

Pena-Bautista, Carmen; (...); Cháfer-Pericás C

Article. 10.1038/s41598-020-73362-z. 2020

Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan

Ribera, E; (...); Hernandez-Novoa, B

Article. 10.1016/j.eimc.2016.11.015. 2018

Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.

Torres Martínez E; (...); Vento M

Article. 10.1016/j.anpedi.2020.03.009. 2020

Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment

Palanques-Pastor T; (...); Poveda Andrés JL

Article. 10.1159/000517813. 2021

Effects of bilingualism on white matter atrophy in mild cognitive impairment: a diffusion tensor imaging study.

Marin-Marin L; (...); Ávila C

Article. 10.1111/ene.14135. 2020

eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Megias-Vericat, JE

Meeting Abstract. 2018

Emotion recognition and baseline cortisol levels relationship in early Alzheimer Disease.

Ferrer-Cairols, I.; (...); Chafer-Pericas, C.

Article. 10.1016/j.biopsycho.2023.108511. 2023

Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages.

Peña-Bautista C; (...); Chafer-Pericas, Consuelo

Article. 10.3390/biomedicines9121812. 2021

Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions: Catalonia and Valencia.

Barceló MA; (...); Saez M

Article. 10.1038/s41598-021-85395-z. 2021

EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN

Badia, F. J.; (...); Shepherd, J.

Meeting Abstract. 2019

Experience of Home Delivery Program in Haemophilia Through an Association of Patients

Megias Vericat, J. E.; (...); Bonanad Boix, S.

Meeting Abstract. 2017

EXPERTS CONSENSUS ON THE FUTURE OF RARE DISEASES CARE AND ORPHAN DRUGS ACCESS IN SPAIN: A DELPHI STUDY

Paz S; (...); Urcelay J

Meeting Abstract. 10.1016/j.jval.2015.09.2016. 2015

Exploratory analysis for the implementation of antineoplastic logarithmic dose banding

Albert-Mari, A; (...); Poveda-Andres, JL

Article. 10.1007/s11096-018-0714-9. 2018

EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY

F, de Andres-Nogales; (...); Martinez, M.

Meeting Abstract. 2019

Facial Onset Sensory and Motor Neuronopathy New Cases, Cognitive Changes, and Pathophysiology

de Boer, EMJ; (...); van Es, MA

Review. 10.1212/CPJ.0000000000000834. 2021

Facial onset sensory and motor neuronopathy: a motor neuron disease with an oligogenic origin?

Article. 10.1080/21678421.2019.1582671. 2019

Fast Declining Prediction in Alzheimer's Disease from Early Clinical Assessment.

Álvarez-Sánchez L; (...); Pericás CC

Article. 10.2174/011570159X332930240925095423. 2024

Fatigue, pain, breathing, voice, fatigability, sleep, rest and vulnerability as meaningful outcomes in SMA care: the patients ' and caregivers' voice

Povedano, M.; (...); Rebollo, P.

Meeting Abstract. 10.1016/j.nmd.2022.07.209. 2022

Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease

Beltran, B; (...); Nos, P

Article. 10.1159/000492626. 2019

Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report

Fernandez-Sanchez, M; (...); Poveda-Andres, JL

Article. 10.1002/bdr2.1942. 2021

Free radicals in Alzheimer's disease: Lipid peroxidation biomarkers

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Review. 10.1016/j.cca.2019.01.021. 2019

GANGLIOSIDE INDUCED DIFFERENTIATION ASSOCIATED PROTEIN 1 MUTATIONS IN SPAIN, A NATIONWIDE STUDY

Sivera, R.; (...); Sevilla, T.

Meeting Abstract. 2016

Genetic and constitutional factors are major contributors to substantia nigra hyperechogenicity

Article. 10.1038/s41598-017-07835-z. 2017

GENETIC DISTRIBUTION IN THE SPANISH TREAT-CMT CONSORTIUM

Barreiro, M.; (...); Sevilla, T.

Meeting Abstract. 2016

Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.

Plaza J; (...); Moret-Tatay I

Article. 10.3390/ijms25073717. 2024

Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

Moreno-Grau, S; (...); GR ACE Study Grp

Article. 10.1016/j.jalz.2019.06.4950. 2019

Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis

Poveda Andres, Jose Luis

Editorial Material. 2022

Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12568. 2017

Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study

Valero-Garcia, S; (...); Spanish Hosp Pharmacy Units

Article. 10.7399/fh.10935. 2018

Hazardous drugs: new challenges, new opportunities.

Valero García S; (...); Poveda Andrés JL

Article. 10.7399/fh.2016.40.2.10462. 2016

Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Solana-Altabella, Antonio; (...); Martinez-Cuadron, David

Article. 10.3390/cancers14081921. 2022

High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.

El-Qutob D; (...); Carrera-Hueso FJ

Article. 10.1016/j.hrtlng.2022.02.003. 2022

Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies

Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo

Article. 10.7399/fh.11729. 2022

Hospitalization budget impact during the COVID-19 pandemic in Spain.

Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.

Article. 10.1186/s13561-021-00340-0. 2021

How can artificial intelligence optimize value-based contracting?

Poveda, Jose Luis; (...); Medrano, Ignacio H.

Letter. 10.1186/s40545-022-00475-3. 2022

Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis

Mazon, M; (...); Marti-Bonmati, L

Review. 10.3389/fnins.2018.00784. 2018

Imaging Biomarkers in Amyotrophic Lateral Sclerosis

Cerda Alberich, Leonor; (...); Marti-Bonmati, Luis

Editorial Material. 10.1007/978-1-0716-1712-0_20. 2022

Imaging of post-traumatic hearing loss.

Mazon, M; (...); Mas-Estelles, F

Article. 10.1016/j.rx.2017.07.005. 2018

Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2016.1231405. 2017

Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart (R) in patients with multiple sclerosis

Edo Solsona MD; (...); Poveda Andrés JL

Article. 10.2147/PPA.S127508. 2017

IMPACT OF ADHERENCE ON SUBCUTANEOUS INTERFERON BETA-1A EFFECTIVENESS ADMINISTERED BY REBISMART (R) IN PATIENTS WITH MULTIPLE SCLEROSIS

Edo-Solsona, M.; (...); Poveda-Andres, J.

Meeting Abstract. 10.1016/j.jval.2016.09.512. 2016

Impact of an antimicrobial stewardship program on critical haematological patients.

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.7399/fh.2017.41.4.10709. 2017

Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1080/10428194.2020.1839650. 2020

Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1038/tpj.2017.19. 2018

Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1097/FPC.0000000000000286. 2017

Impact of SARS-CoV-2 infection and COVID-19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain

Garcia-Casanova, Pilar H.; (...); Vazquez-Costa, Juan F.

Article. 10.1111/ene.16465. 2024

Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation

Ruiz J; (...); Aliño SF

Article. 10.3390/ijms160920168. 2015

Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

Badia X; (...); Hernández C

Article. 10.1186/s13023-020-01507-4. 2020

Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia

Eduardo Megias, Juan; (...); Angel Sanz, Miguel

Meeting Abstract. 2015

Impact of voriconazole plasma concentrations on treatment response in critically ill patients

Ruiz, J; (...); Ramirez, P

Article. 10.1111/jcpt.12817. 2019

Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases

Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL

Article. 10.7399/fh.11262. 2020

Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1159/000478969. 2018

Improving Care and Empowering Adults Living with SMA: A Call to Action in the New Treatment Era.

Walter MC; (...); Servais L

Article. 10.3233/JND-200611. 2021

Increased pulsatility index supports diagnosis of vascular parkinsonism versus idiopathic Parkinson's disease.

Caba LM; (...); Martin AL

Article. 10.1016/j.nrl.2017.10.008. 2017

Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Vericat, JEM; (...); Bonanad, S

Meeting Abstract. 2018

Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

Megias-Vericat, Juan Eduardo; (...); Bonanad, Santiago

Meeting Abstract. 10.1182/blood.V128.22.3802.3802. 2016

Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy

Bastida, G; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019

Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2017.1323267. 2017

Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.

Ruiz J; (...); Poveda JL

Article. 10.23736/S0026-4946.18.04978-2. 2018

Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1097/FPC.0000000000000431. 2021

Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia

Eduardo Megias, Juan; (...); Angel Sanz, Miguel

Meeting Abstract. 2015

Inner ear malformations: a practical diagnostic approach.

Mazon, M; (...); Mas-Estelles, F

Article. 10.1016/j.rx.2016.09.009. 2017

Insights from a 7-Year Dementia Cohort (VALCODIS): ApoE Genotype Evaluation.

Baquero, Miguel; (...); Chafer-Pericas, Consuelo

Article. 10.3390/jcm13164735. 2024

Insights into phenotypic variability caused by GARS1 pathogenic variants.

Jiménez-Jiménez J; (...); Sivera R

Article. 10.1111/ene.16416. 2024

Interdisciplinary recommendations document to improve adherence in patients with chronic inflammatory diseases: Adhing recommendations.

Bermejo San José F; (...); Sanromán-Álvarez L

Article. 10.7399/fh.2016.40.5.10180. 2016

Intermediate Repeat Expansion in the ATXN2 Gene as a Risk Factor in the ALS and FTD Spanish Population.

Borrego-Hernandez, Daniel; (...); Garcia-Redondo, Alberto

Article. 10.3390/biomedicines12020356. 2024

Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12842. 2019

Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.

Solana-Altabella A; (...); Poveda JL

Article. 10.1177/1078155220904410. 2020

Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19

Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP

Article. 10.1136/ejhpharm-2020-002322. 2020

Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024

Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.

Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula

Article. 10.3390/antibiotics13080706. 2024

Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer's Disease

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Article. 10.3390/antiox9050407. 2020

La reserva cognitiva como factor modulador del impacto de la cirugía sobre la memoria visual y la denominación en pacientes con epilepsia del lóbulo temporal.

Cano-Lopez, I; (...); Gonzalez-Bono, E

Article. 10.33588/rn.7308.2021109. 2021

Labyrinthine Bifurcation of the Facial Nerve

Saro-Buendia, Miguel; (...); Carceller, Miguel Armengot

Article. 10.1007/s12070-023-03977-x. 2023

Lifesaving Treatments for Spinal Muscular Atrophy: Global Access and Availability

Armengol, Victor D.; (...); Roy, Bhaskar

Meeting Abstract. 2023

Life-Saving Treatments for Spinal Muscular Atrophy: Global Access and Availability.

Armengol, Victor D; (...); Roy, Bhaskar

Article. 10.1212/CPJ.0000000000200224. 2024

Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis

Pena-Bautista, Carmen; (...); Cháfer-Pericás C

Article. 10.3390/antiox10071043. 2021

Lipid peroxidation biomarkers correlation with medial temporal atrophy in early Alzheimer Disease

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Article. 10.1016/j.neuint.2019.104519. 2019

Lipid peroxidation in neurodegeneration.

Review. 10.1016/j.cca.2019.07.037. 2019

Lipids as early and minimally invasive biomarkers for Alzheimer disease.

Casas-Fernandez, Esther; (...); Chafer-Pericas, Consuelo

Article. 10.2174/1570159X19666211102150955. 2021

Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.

Megías-Vericat JE; (...); Poveda-Andrés JL

Article. 2021

Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.

Vázquez Polo A; (...); Vázquez Costa JF

Article. 10.20960/nh.03946. 2022

Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A

Bonanad, S; (...); Santos, S

Article. 10.1007/s12325-021-01853-0. 2021

Measuring Outcomes in Adults with Spinal Muscular Atrophy - Challenges and Future Directions - Meeting Report.

Sansone VA; (...); Hagenacker T

Article. 10.3233/JND-200534. 2020

MEASURING THE EXPERIENCE OF LIVING WITH SPINAL MUSCULAR ATROPHY: THE ROLE OF THE SMA INDEPENDENCE SCALE

Vazquez, J. F.; (...); Madruga, M.

Meeting Abstract. 2022

Medical help-seeking intentions among patients with early Alzheimer's disease

Villarejo-Galende, Alberto; (...); Maurino, Jorge

Article. 10.3389/fpsyt.2023.1290002. 2023

Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Article. 10.3390/cancers14030596. 2022

Metabolomics study to identify plasma biomarkers in alzheimer disease: ApoE genotype effect.

Article. 10.1016/j.jpba.2019.113088. 2020

Metyrapone as treatment in the neonatal McCune-Albright syndrome

de Mingo, Carmen; (...); Garcia-Robles, Ana

Article. 10.1515/jpem-2020-0036. 2020

Mild Developmental Foreign Accent Syndrome and Psychiatric Comorbidity: Altered White Matter Integrity in Speech and Emotion Regulation Networks

Berthier, ML; (...); Davila, G

Article. 10.3389/fnhum.2016.00399. 2016

Minimal detectable change and minimal clinically important difference in spinal muscular atrophy patients.

Vázquez-Costa JF, Hervás D

Letter. 10.1111/ene.14780. 2021

Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis.

Peña-Bautista C; (...); Ferreira D

Article. 10.3389/fmolb.2023.1193458. 2023

Monitoring coagulation factors during surgery. A systematic review

Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11766. 2021

Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).

Valero-García S; (...); Delgado-Sánchez O

Article. 10.7399/fh.11655. 2021

MONITORING PROGRESSION OF AMYOTROPHIC LATERAL SCLEROSIS USING ULTRASOUND MORPHO-TEXTURAL MUSCLE BIOMARKERS: A PILOT STUDY

Martinez-Paya, JJ; (...); del Bano-Aledo, ME

Article. 10.1016/j.ultrasmedbio.2017.09.013. 2018

Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program.

Fernandez-Megia, MJ; (...); Poveda Andrés JL

Article. 10.7399/fh.10793. 2018

Moral reasoning and moral conflict in patients of the amyotrophic lateral sclerosis - Frontotemporal dementia spectrum.

Serrano-Pastor, Lucas; (...); Vazquez-Costa, Juan F

Article. 10.1080/17470919.2020.1850521. 2020

Multimodal non-invasive imaging in choroidal rupture secondary to a firework explosion.

Placinta IA; (...); Cisneros-Lanuza Á

Case Reports. 10.1016/j.oftal.2018.06.009. 2019

Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments

Gomez-Cebrian, N; (...); Pineda-Lucena, A

Review. 10.3390/cancers13184544. 2021

MUSCULAR ECHOVARIATION: A NEW BIOMARKER IN AMYOTROPHIC LATERAL SCLEROSIS

Martinez-Paya, JJ; (...); Medina-Mirapeix, F

Article. 10.1016/j.ultrasmedbio.2017.02.002. 2017

Mutations in MME cause autosomal recessive late-onset CMT type-2 disease

Carrera, MF; (...); Sevilla, T

Meeting Abstract. 2018

N. VICTOR JIMENEZ TORRES (1942-2015) IN MEMORIAM

Climente Martí M, Poveda Andrés JL, Culebras J

Biographical-Item. 10.3305/nh.2015.32.4.9704. 2015

National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)

Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel

Correction. 10.7399/fh.11740. 2021

National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis

Meeting Abstract. 10.1182/blood-2022-169938. 2022

Natural history data in adults with SMA

Vazquez-Costa, JF

Letter. 10.1016/S1474-4422(20)30183-6. 2020

Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen

Andres-Benito, Pol; (...); Povedano, Monica

Article. 10.3390/ijms25073810. 2024

Neuropsychological assessment and cortisol levels in biofluids from early Alzheimer's disease patients

Pena-Bautista, C.; (...); Chafer-Pericas, C.

Article. 10.1016/j.exger.2019.05.007. 2019

New approach for early and specific Alzheimer disease diagnosis from different plasma biomarkers.

Forte, Anabel; (...); Chafer-Pericas, Consuelo

Article. 10.1016/j.cca.2024.117842. 2024

New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024

New insights into the genetic etiology of Alzheimer's disease and related dementias

Bellenguez, Celine; (...); CHARGE

Article. 10.1038/s41588-022-01024-z. 2022

New insights into the pathophysiology of fasciculations in amyotrophic lateral sclerosis: An ultrasound study

Article. 10.1016/j.clinph.2018.09.014. 2018

New screening approach for Alzheimer's disease risk assessment from urine lipid peroxidation compounds.

Peña-Bautista C; (...); Chafer-Pericas, C

Article. 10.1038/s41598-019-50837-2. 2019

Novel Ultrasensitive Detection Technologies for the Identification of Early and Minimally Invasive Alzheimer's Disease Blood Biomarkers.

Alvarez-Sanchez, Lourdes; (...); Chafer-Pericas, Consuelo

Article. 10.3233/JAD-215093. 2022

Nusinersen in adult patients with 5q spinal muscular atrophy: Amulticenter observational cohorts' study.

Vazquez-Costa, Juan F.; (...); Hervas, David

Article. 10.1111/ene.15501. 2022

Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022

Obstructive sleep apnea and Alzheimer's disease-related cerebrospinal fluid biomarkers in mild cognitive impairment.

Díaz-Román M; (...); Gómez E

Article. 10.1093/sleep/zsaa133. 2021

ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023

Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023

Omics-based Biomarkers for the Early Alzheimer Disease Diagnosis and Reliable Therapeutic Targets Development

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Review. 10.2174/1570159X16666180926123722. 2019

Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Poveda, JL

Meeting Abstract. 2018

OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT

Flores-Moreno, S.; (...); Gil, A.

Meeting Abstract. 2024

Oxidative Damage of DNA as Early Marker of Alzheimer's Disease.

Article. 10.3390/ijms20246136. 2019

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Garcia-Robles, Ana; (...); Carrascosa, MA

Article. 10.3389/fped.2020.00372. 2020

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Correction. 10.3389/fped.2021.834454. 2022

Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project

Morillo-Verdugo, R; (...); Diaz-Olmo, J

Article. 10.7399/fh.11719. 2021

Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.

Morillo-Verdugo R; (...); Díaz-Olmo J

Article. 2021

Pediatric inherited peripheral neuropathy: a prospective study at a Spanish referral center

Argente-Escrig H; (...); Sevilla T

Article. 10.1002/acn3.51432. 2021

Person-centered Assessment in Early Alzheimers Disease (P1-1.Virtual)

Villarejo Galende, Alberto; (...); Maurino, Jorge

Meeting Abstract. 2022

Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy

Margusino-Framiñán L; (...); Morillo-Verdugo R

Article. 10.7399/fh.11498. 2020

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study

Timmers, M; (...); Engelborghs, S

Article. 10.1186/s13195-018-0415-6. 2018

Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis

Article. 10.3390/ijms26041760. 2025

Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.2174/1389200218666171101124931. 2018

Pharmacogenomics and the treatment of acute myeloid leukemia

Megías-Vericat JE; (...); Aliño SF

Review. 10.2217/pgs-2016-0055. 2016

Pharmacometabolomics by NMR in Oncology: A Systematic Review.

Gómez-Cebrián N; (...); Pineda-Lucena A

Article. 10.3390/ph14101015. 2021

Pharmacotherapeutic management of advanced therapy medicinal products

Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia

Article. 10.7399/fh.13036. 2022

Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.

Calleja Hernández MÁ; (...); Aragon, B

Article. 10.7399/fh.2017.41.1.10463. 2017

Phenotype and natural history of inherited neuropathies caused by HSJ1 c.352+1G > A mutation

Frasquet M; (...); Sevilla T

Letter. 10.1136/jnnp-2015-312890. 2016

Phenotypical features of two patients diagnosed with PHARC syndrome and carriers of a new homozygous mutation in the ABHD12 gene

Frasquet, M; (...); Sevilla, T

Article. 10.1016/j.jns.2018.02.021. 2018

Physical Activity In Haemophilia: Hemorrhagic Risk And Factor Levels (myPKFiT)

Querol-Fuentes, F; (...); Bonanad, S

Meeting Abstract. 2017

Pilot evaluation of home delivery programme in haemophilia

Megias-Vericat, JE; (...); Poveda-Andres, JL

Article. 10.1111/jcpt.12718. 2018

PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS

Vericat, JEM; (...); Iorio, A

Meeting Abstract. 2020

Plasma alterations in cholinergic and serotonergic systems in early Alzheimer Disease: Diagnosis utility.

Article. 10.1016/j.cca.2019.10.023. 2020

Plasma isoprostanoids assessment as Alzheimer's disease progression biomarkers.

Vázquez-Costa JF, Bataller L, Vílchez JJ

Article. 10.1111/jnc.15183. 2020

Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer Disease detection

Pena-Bautista, C; (...); Chafer-Pericas, C

Article. 10.1016/j.freeradbiomed.2018.06.038. 2018

Plasma Lipidomics Approach in Early and Specific Alzheimer's Disease Diagnosis.

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Article. 10.3390/jcm11175030. 2022

Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Article. 10.1016/j.jprot.2019.04.008. 2019

Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis

Megías-Vericat JE; (...); Aliño SF

Letter. 10.1038/tpj.2015.79. 2016

Posterior Lingual Abscess; Report of Two Cases.

Saro-Buendia, Miguel; (...); Armengot Carceller, Miguel

Case Reports. 10.22037/aaem.v11i1.1860. 2023

Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease

Garcia-Blanco, Ana; (...); Chafer-Pericas, Consuelo

Review. 10.1016/j.jns.2017.01.020. 2017

Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process

Valero, S; (...); Poveda, JL

Article. 10.1016/j.yrtph.2018.03.001. 2018

PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019

Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.

García-Robles A; (...); Aguar-Carrascosa M

Letter. 10.1016/j.anpedi.2020.06.008. 2021

Preparation and administration of insulin infusions in neonatology: A national survey.

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Article. 10.1016/j.anpede.2020.06.015. 2021

Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

Presenilin-1 Mutations Are a Cause of Primary Lateral Sclerosis-Like Syndrome

Vazquez-Costa, JF; (...); SEVILLA, T

Article. 10.3389/fnmol.2021.721047. 2021

Primary Lateral Sclerosis and Hereditary Spastic Paraplegia in Sporadic Patients. An important distinction in descriptive studies

Letter. 10.1002/ana.24671. 2016

Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review

Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11780. 2021

Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease.

López-Cuevas R; (...); Cháfer-Pericás C

Article. 10.1016/j.nrl.2020.07.026. 2020

Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease.

Lopez-Cuevas, R; (...); Chafer-Pericas, C

Article. 10.1016/j.nrleng.2020.07.024. 2023

Prostaglandin Injection After Arterial Compromise Related to Hyaluronic Acid Filler

Letter. 10.1097/DSS.0000000000001046. 2017

Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker

Perez-Alenda, S; (...); Querol, F

Letter. 10.1111/hae.13388. 2018

Quantitative Muscle Ultrasonography Using Textural Analysis in Amyotrophic Lateral Sclerosis

Martinez-Paya, JJ; (...); Medina-Mirapeix, F

Article. 10.1177/0161734617711370. 2017

Quantitative neuromuscular ultrasound analysis as biomarkers in amyotrophic lateral sclerosis

Rios-Diaz, J; (...); Martinez-Paya, JJ

Article. 10.1007/s00330-018-5943-8. 2019

Radiological evaluation of the postsurgical middle ear.

Mazon, M.; (...); Carreres-Polo, J.

Article. 10.1016/j.rx.2021.04.005. 2021

Radiological evaluation of the postsurgical middle ear.

Mazón M; (...); Carreres-Polo J

Article. 10.1016/j.rxeng.2021.04.006. 2021

Radiology of external ear: indications, normal anatomy, and pathological processes.

Mazon, M; (...); Mas-Estelles, F

Article. 10.1016/j.rx.2015.08.003. 2016

Recent evidence in epigenomics and proteomics biomarkers for early and minimally invasive diagnosis of Alzheimer's and Parkinson's diseases.

Mayo, Sonia; (...); Chafer-Pericas, Consuelo

Review. 10.2174/1570159X19666201223154009. 2020

Reduction in alert fatigue in an assisted electronic prescribing system, through the Lean Six Sigma methodology.

Cuéllar Monreal MJ; (...); Poveda Andrés JL

Article. 10.7399/fh.2017.41.1.10434. 2017

Relationship between neuroimaging and emotion recognition in Mild Cognitive Impairment patients.

Gandia-Ferrero, Maria Teresa; (...); Marti-Bonmati, Luis

Article. 10.1016/j.bbr.2023.114844. 2024

Relationship between Plasma Lipid Profile and Cognitive Status in Early Alzheimer Disease.

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Article. 10.3390/ijms25105317. 2024

Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease

Timmers, M; (...); Streffer, JR

Article. 10.1016/j.neurobiolaging.2019.03.016. 2019

Reliable determination of new lipid peroxidation compounds as potential early Alzheimer Disease biomarkers

Garcia-Blanco, Ana; (...); Chafer-Pericas, Consuelo

Article. 10.1016/j.talanta.2018.03.002. 2018

Risdiplam in non-sitter patients aged 16years and older with 5q spinal muscular atrophy.

Nungo Garzon, Nancy Carolina; (...); Vazquez-Costa, Juan F

Article. 10.1002/mus.27804. 2023

Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis

Isabel Moreno-Gambin, Maria; (...); Vázquez-Costa JF

Article. 10.1007/s00415-021-10729-w. 2021

Safety and efficacy of botulinum toxin A for the treatment of spasticity in amyotrophic lateral sclerosis: results of a pilot study

Vázquez-Costa JF; (...); Sevilla T

Article. 10.1007/s00415-016-8223-z. 2016

Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.

Sole, A; (...); Peman, J

Article. 10.1111/ajt.14580. 2018

SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11565. 2020

Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice

Aguas Peris M; (...); Nos, P

Article. 10.1097/MIB.0000000000001182. 2017

Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice

Aguas, M; (...); Nos, P

Meeting Abstract. 2017

SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization

Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis

Article. 10.1111/jcpt.13703. 2022

SONOELASTOGRAPHY FOR THE ASSESSMENT OF MUSCLE CHANGES IN AMYOTROPHIC LATERAL SCLEROSIS: RESULTS OF A PILOT STUDY

Martinez-Paya, JJ; (...); Vazquez-Costa, JF

Article. 10.1016/j.ultrasmedbio.2018.08.009. 2018

Spinal Muscular Atrophy Update in Best Practices: Recommendations for Diagnosis Considerations.

Schroth, Mary; (...); Vazquez-Costa, Juan F.

Article. 10.1212/CPJ.0000000000200310. 2024

STATISTICAL SOLUTIONS FOR ANALYTIC CHALLENGES IN REGISTRIES FOR HTA-PURPOSES

Fekete, I; (...); Volmer, T

Meeting Abstract. 2020

Stress and neurodegeneration.

Review. 10.1016/j.cca.2020.01.019. 2020

Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia

Megías-Vericat JE; (...); Montesinos P

Review. 10.3390/pharmaceutics14040878. 2022

The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity

Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar

Article. 10.1007/s00431-022-04628-z. 2022

The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.

Gil-Nagel A; (...); Gil A

Article. 10.1016/j.yebeh.2022.108711. 2022

The cross-sectional area of the median nerve: An independent prognostic biomarker in amyotrophic lateral sclerosis

Martinez-Paya, J. J.; (...); Vazquez-Costa, J. F.

Article. 10.1016/j.nrl.2022.01.008. 2024

The cross-sectional area of the median nerve: An independent prognostic biomarker in amyotrophic lateral sclerosis.

Martinez-Paya, J J; (...); Vazquez-Costa, J F

Article. 10.1016/j.nrleng.2024.07.003. 2024

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE epsilon 4 Non-carriers

Sanchez-Juan, P; (...); DEGESCO Consortium

Article. 10.3389/fnagi.2019.00327. 2019

The role of DNAJB2 in amyotrophic lateral sclerosis

Frasquet M, Vázquez-Costa JF, Sevilla T

Letter. 10.1093/brain/aww154. 2016

The role ofDNAJB2in amyotrophic lateral sclerosis

Marina Frasquet, Juan F. Vázquez-Costa, Teresa Sevilla

Article. 2016

The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).

Badia, Xavier; (...); Valles, Joan-Antoni

Article. 10.1186/s13023-024-03324-5. 2024

The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus

Torrent-Farnell, J; (...); Lizan, L

Article. 10.1016/j.healthpol.2018.03.002. 2018

The width of the third ventricle associates with cognition and behaviour in motor neuron disease

Vázquez-Costa JF, Arlandis S

Article. 10.1111/ane.13022. 2019

Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy.

Pascual-Camps I; (...); Espana-Gregori E

Article. 10.1080/01676830.2018.1435694. 2018

Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.

Marques MR; (...); Mangas-Sanjuan V

Article. 10.1111/apa.14944. 2020

Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy

Del Rio-Bermudez, C; (...); Poveda, JL

Editorial Material. 10.1186/s40545-020-00276-6. 2020

Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.

Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis

Article. 10.1136/ejhpharm-2024-004184. 2024

Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs.

Megías Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.rx.2015.01.008. 2015

Treatment of patients with spinal muscular atrophy 5q: Towards a new protocol.

Gomez-Andres, D., Martinez-Moreno, M., Vazquez-Costa, J. F.

Letter. 10.1016/j.nrl.2020.10.003. 2021

Treatment of patients with spinal muscular atrophy 5q: towards a new protocol.

Gómez-Andrés D, Martínez-Moreno M, Vázquez-Costa JF

Letter. 10.1016/j.nrleng.2020.10.005. 2021

Treatment of spinal muscular atrophy in European countries: A call to action

Vazquez-Costa, Juan F.; (...); Cattinari, Maria Grazia

Article. 10.1111/ene.15522. 2022

Ultrasound-guided lumbar puncture for nusinersen administration in spinal muscular atrophy patients.

Veiga-Canuto D; (...); Aparici F

Article. 10.1111/ene.14586. 2021

Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?

Bejar, S; (...); Mateu, PN

Meeting Abstract. 2020

Urinary symptoms in patients with amyotrophic lateral sclerosis.

Letter. 10.1016/j.nrl.2019.01.003. 2020

Urodynamic findings in amyotrophic lateral sclerosis patients with lower urinary tract symptoms: Results from a pilot study

Arlandis, S; (...); Broseta, E

Article. 10.1002/nau.22976. 2017

Urodynamic findings in amyotrophic lateral sclerosis patients with lower urinary tract symptoms: Results from a pilot study.

Arlandis, Salvador; (...); Broseta, Enrique

Article. 2016

Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy

Garcia, SV; (...); Andres, JLP

Article. 10.1016/j.yrtph.2018.10.002. 2018

Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann Pick Type C patients

García-Robles AA; (...); Poveda JL

Letter. 10.1016/j.jns.2016.04.048. 2016

USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

Dominguez Hernandez, L.; (...); Gomez Segui, I

Meeting Abstract. 2019

Use of Tachosil (R) as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation

Rahhal-Ortuno, M; (...); Cisneros-Lanuza, AL

Article. 10.4103/ijo.IJO_1573_18. 2019

Validated analytical method to determine new salivary lipid peroxidation compounds as potential neurodegenerative biomarkers.